Hints and tips:
Showing results for Fudickar v. CR Bard Inc
...“My identity is complicated, because it was chosen for me,” she said in an interview with the fashion magazine CR. She “came out” as a robot in 2018....
...US healthcare-equipment maker CR Bard is flying high a day after Becton Dickinson, the New Jersey-based medical technology company, struck a $24bn cash-and-shares takeover deal for the company....
...Tim Ring, Bard’s chief executive, will join the BD board when the deal closes, along with one other Bard director....
...By Sunday night Becton, which has a market value of $40bn, announced it was spending $24bn to snatch rival CR Bard, ramping its leverage to nearly five times....
...But note what the SEC puts out in support of its civil charges (this is from paras 60 to 71 of the filing): Within CR Intrinsic, Martoma claimed to have unique insight into the Phase II Trial....
...Medivance, a US developer of therapeutic temperature management, signed a definitive agreement to be acquired by CR Bard in a deal expected to complete in the fourth quarter of 2011....
...A new version of its CR-V small SUV begins production in September, and it plans to renew its small Jazz at a later date....
...CR Bard said it had agreed to buy Medivance, a US developer of therapeutic temperature management in which MDY has a 10.4 per cent holding....
...But before the month was out CR Bard, a US medical devices specialist listed on the New York Stock Exchange with a market capitalisation of $7.4bn, launched a bid at 85p a share, valuing the equity at £43.8m...
...The law firm secured a victory for CR Bard, a medical technologies company, after $658m in litigation that had raged for decades with its rival WL Gore & Associates....
...Honda is also expected to introduce a redesigned CR-V late next year....
...Boston Scientific gained 7.9 per cent to $6.18 and CR Bard added 2 per cent to $81.56....
International Edition